Last Posted: Aug 08, 2019
- Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies.
Yamazaki Yu et al. Nature reviews. Neurology 2019 Jul - Sleep and Memory: The Promise of Precision Medicine.
Carter Patricia et al. Sleep medicine clinics 2019 Sep 14(3) 371-378 - A Novel Ensemble-Based Machine Learning Algorithm to Predict the Conversion From Mild Cognitive Impairment to Alzheimer's Disease Using Socio-Demographic Characteristics, Clinical Information, and Neuropsychological Measures.
Grassi Massimiliano et al. Frontiers in neurology 2019 10756 - Towards clinical utility of polygenic risk scores.
Lambert Samuel A et al. Human molecular genetics 2019 Jul - Should you find out if you’re at risk of Alzheimer’s?
Genomes 2 People, Wall Street Journal, July 2019 - A Weighted Genetic Risk Score Based on Four APOE-Independent Alzheimer's Disease Risk Loci May Supplement APOE E4 for Better Disease Prediction.
Zhang Chunyu et al. Journal of molecular neuroscience : MN 2019 Jul - Application of artificial neural network model in diagnosis of Alzheimer's disease.
Wang Naibo et al. BMC neurology 2019 Jul 19(1) 154 - Harnessing digital technology to predict, diagnose, monitor, and develop treatments for brain disorders.
Stroud Clare et al. NPJ digital medicine 2019 244 - Using Deep Siamese Neural Networks for Detection of Brain Asymmetries Associated with Alzheimer's Disease and Mild Cognitive Impairment.
Liu Chin-Fu et al. Magnetic resonance imaging 2019 Jul - Public Understanding and Opinions regarding Genetic Research on Alzheimer's Disease.
Kent Saida et al. Public health genomics 2019 Jul (5-6) 228-237
.png)
No hay comentarios:
Publicar un comentario